VistaGen Therapeutics Inc/ US92840H4002 /
| 2024-04-23 9:24:05 PM | Chg. +0.1000 | Volume | Bid9:24:16 PM | Ask9:24:16 PM | High | Low |
|---|---|---|---|---|---|---|
| 4.8800USD | +2.09% | 167,267 Turnover: 702,716.8448 |
4.8700Bid Size: 100 | 4.8900Ask Size: 400 | 5.0000 | 4.7800 |
GlobeNewswire
2022-03-24
VistaGen to Participate in Fireside Chat at Maxim Group 2022 Virtual Growth Conference
GlobeNewswire
2022-02-10
VistaGen Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2022-02-07
VistaGen Therapeutics to Report Fiscal Year 2022 Third Quarter Financial Results on February 10, 202...
GlobeNewswire
2021-11-16
VistaGen Therapeutics to Present at the Jefferies London Healthcare Conference
GlobeNewswire
2021-11-10
VistaGen Therapeutics Reports Fiscal Year 2022 Second Quarter Financial Results and Provides Corpora...
GlobeNewswire
2021-11-04
VistaGen Therapeutics to Report Fiscal Year 2022 Second Quarter Financial Results and Recent Develop...
GlobeNewswire
2021-10-14
VistaGen Therapeutics Expands Clinical Development of PH94B with Initiation of Phase 2A Trial in Adj...
GlobeNewswire
2021-10-05
VistaGen Therapeutics Reports New Preclinical Mechanism of Action Data Supporting PH94B’s Potential ...
GlobeNewswire
2021-09-13
VistaGen Therapeutics Further Advances PALISADE Phase 3 Program for PH94B in Social Anxiety Disorder...
GlobeNewswire
2021-09-08
VistaGen Therapeutics to Participate in Baird’s 2021 Global Healthcare Conference
GlobeNewswire
2021-08-12
VistaGen Therapeutics Reports Fiscal Year 2022 First Quarter Financial Results and Provides Corporat...
GlobeNewswire
2021-08-09
VistaGen Therapeutics to Report Fiscal Year 2022 First Quarter Financial Results and Host Conference...
GlobeNewswire
2021-08-02
VistaGen Therapeutics to Participate in Canaccord Genuity 41st Annual Growth Conference
GlobeNewswire
2021-07-22
VistaGen Therapeutics Announces Appointment of Maggie FitzPatrick to its Board of Directors
GlobeNewswire
2021-07-09
VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
GlobeNewswire
2021-07-07
VistaGen Therapeutics Announces Appointment of Mary L. Rotunno to its Board of Directors
GlobeNewswire
2021-06-29
VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-06-25
VistaGen Therapeutics to Report 2021 Fiscal Year End Financial Results, Provide a Business Update an...
GlobeNewswire
2021-05-26
VistaGen Therapeutics Initiates PALISADE Phase 3 Trial of PH94B in Social Anxiety Disorder
GlobeNewswire
2021-05-04
VistaGen Therapeutics Announces Appointment of Ann Cunningham as Chief Commercial Officer
GlobeNewswire
2021-04-27
VistaGen Therapeutics Announces Appointment of Joanne Curley, Ph.D. to its Board of Directors
GlobeNewswire
2021-03-22
VistaGen’s Poster Presentation at the Anxiety and Depression Association of America’s 2021 Annual Co...
GlobeNewswire
2021-03-16
VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March
